Goldenwell Biotech, Inc. (GWLL) stock
GWLLOTCFood and Kindred ProductsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 16, 2026Score 4/30
$0.65+0.05 (+8.33%)
Close on Oct 19, 2026Market cap $64.35MP/E –Yield –
Goldenwell Biotech operating margin
Operating margin is operating income as a percentage of revenue.
Goldenwell Biotech's operating margin for the twelve months ending Jun 30, 2026 was -208729.1%. For fiscal 2025 it was -206047.3%, against -88559.7% the year before. The highest annual figure on record is -740.7% in fiscal 2021.
Annual operating margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -206047.3% | −117487.6 |
| FY2024 | Dec 31, 2024 | -88559.7% | −82251.1 |
| FY2023 | Dec 31, 2023 | -6308.6% | −4247.7 |
| FY2022 | Dec 31, 2022 | -2060.9% | −1320.2 |
| FY2021 | Dec 31, 2021 | -740.7% | – |
Quarterly operating margin
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| Q4 FY2025 | Dec 31, 2025 | -41627.3% | −31814.2 |
| Q2 FY2024 | Jun 30, 2024 | -34402.9% | −32039.6 |
| Q4 FY2023 | Dec 31, 2023 | -7999.6% | −7989.1 |
| Q3 FY2023 | Sep 30, 2023 | -9268.6% | −8546.8 |
| Q2 FY2023 | Jun 30, 2023 | -9813.0% | −1403.2 |
| Q1 FY2023 | Mar 31, 2023 | -2363.3% | −320.2 |
| Q3 FY2022 | Sep 30, 2022 | -10.5% | +718.7 |
| Q2 FY2022 | Jun 30, 2022 | -721.8% | – |
| Q1 FY2022 | Mar 31, 2022 | -8409.8% | – |
| Q4 FY2021 | Dec 31, 2021 | -2043.1% | – |
| Q3 FY2021 | Sep 30, 2021 | -729.2% | – |
See a number that looks wrong?